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In situ hybridization using a cDNA probe complementary to glutathione S-transferase
Yb-j mRNA was utilized to isolate a glutathione S-transferase Ybi gene from a rat liver genomic
library. DNA sequence analysis incorporating "gene walking" strategies revealed that the Ybi
gene spans approximately 5.5 Kb, is comprised of eight exons separated by seven introns and
is 99% homologous to the Ybi cDNA clone pGTA/C44. The transcription start site, which
maps 29 bp downstream of the TATA element, was determined by primer extension analysis.
Gene fragments containing the Ybi promoter (and various deletions of the promoter
region) were inserted upstream of the structural gene encoding chloramphenicol acetyl
transferase (CAT). When these chimeric genes were transfected into mammalian cells, CAT
assays revealed that the Ybi minimal promoter is contained within an 80 bp DNA fragment
which contains a TATA element, a transcription initiation site and 50 bp of sequence upstream
of the TATA element. Contrary to in vivo studies which have shown that Ybi 9®*^® activity is
induced in response to phenobarbital and 3-methylcholanthrene administration, no elevation in
activity was observed when mammalian hepatoma cells which had been transfected with the
chimeric genes were treated with these xenobiotics. These data suggests that the regulatory
element which confers xenobiotic inducibility is absent from the first 1700 bp of the Ybi 9®r>e.
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The glutathione S-transferases play a predominant role in protection against
carcinogenesis. The famiiy of isozymes provide several detoxification mechanisms against
cytotoxic drugs and carcinogens. Therefore, it is vital to obtain an understanding of the
processes involved in the regulation of these enzymes.
The cDNA clones representing the Ya, Yb-], Yb2 and Yc mRNAs have been isolated
and used to demonstrate that both the Ya and Yb subunits are induced in the livers of rats
administered various xenobiotics, including 3-methylcholanthrene and phenobarbital (1). The
induction has been attributed to an increase in transcriptional activity of the genes (2). The
mechanism by which the glutathione S-transferase Yb genes are regulated is not well
understood. The work described in this text is aimed at addressing the question of how the
Ybi gene is regulated. A necessary step towards urderstanding regulation is isoiation of
structural gene. In this work, a Yb^ cDNA clone was utilized as a probe in order to isolate the
Yb-| structural gene from a rat liver genomic library. Characterization of the gene was
accomplished via nucleotide sequence analysis and facilitated direct comparison of structural
as well as regulatory components of the Ybi gene to those of other transferase genes.
Isolation and characterization of the Ybi gene also facilitated the initiation of a study aimed at
identifying key cis- and trans-acting regulatory elements which are responsible for the
elevation of gene activity in response to xenobiotic administration.
Historical Perspective
Eric Boyland was the first to recognize the significance of detoxification of xenobiotics
by glutathione conjugation. In 1936, Boyland and Levi showed that a mercapturic acid was
among the urinary metabolites of anthracene (3). At that time, the origin of mercapturic acids
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was not known. Two decades later (1959), Boyland and others demonstrated that the acids
were derived from glutathione conjugates (4-7).
The first demonstration of glutathione conjugation in vitro was the reaction of
glutathione with the epoxide, 1,2-epoxy, 1,2,3,4 tetrahydronaphthalene, to give S-(2-
hydroxy,1,2,3,4 tetrahydro-1-naphthyl)-glutathione (8). The corresponding mercapturic acid
N-acetyl-S-2 hydroxy-1,2,3,4, tetrahydronaphthyl L-cysteine was recovered from the urine of
rabbits administered the epoxide (9). An analogous glutathione conjugate and mercapturic
acid were obtained as metabolites of naphthalene. S-(2-hydroxy-1,2 dihydronaphthyl)-
cysteine was isolated from incubations of naphthalene with rat liver slices (10) and N-acetyl-
S(2-hydroxy-1,2 dihydro-naphthyl) cysteine was isolated from rats dosed with naphthalene.
These findings provided evidence that these epoxides were electrophilic metabolites
of polyaromatic hydrocarbons and ultimately led to the discovery of the glutathione S-
transferases in 1960. Booth and coworkers were the first to report enzymic catalysis of
giutathione conjugation by the rat-liver-soluble supernatant fraction (10). The following year,
the group demonstrated glutathione transferase activity for a number of eiectrophiles,
including 1,2-dichioro-4-nitrobenzene-benzyl chioride, bromoethane, ethyl methano-
sulphonate, bromosulfophthalein, and 1,2-epoxy 1,2,3,4 tetrahydronaphthalene together with
those derived from naphthaiene and anthracene by microsomal activation (11). Another
demonstration of transferase activity was made at about the same time by Combes and
Stakelum, who demonstrated that rat liver cytosol catalyzed glutathione conjugation of
bromosulfophthaiein (12).
The first transferase purified was isolated as a binding protein and called ligandin by
Ketterer et al. in 1967 (13) and Litwack et al. in 1971 (14). The enzyme was tested against 1,2
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dichloro-4 nitrobenzene, a favored substrate for glutathione S-aryl chloride transferase, but
was found to have negligible activity (15). Later that year, the identity of ligandin with
glutathione S-transferase B was recognized by Jakoby and his colleagues in collaboration with
Arias and his group (16).
Nomenclature
Originally, the glutathione S-transferases were defined in the traditional manner
according to the type of substrate. Examples include glutathione-S-aryl chloride transferase
(17), glutathione-S-epoxide transferase (18), and glutathione-S-alkene transferase (19).
Subsequently, it became obvious that although a number of different transferases existed,
certain substrates were utilized by more than one enzyme. It is now accepted that individual
glutathione transferases cannot be defined according to the chemical nature of the substrate.
In 1973, Clark et al. discovered that chloro-2-4 dinitrobenzene was a substrate for all
known glutathione transferases (20). Using this substrate, four transferases were isolated by
Jakoby et al. from the rat-liver-soluble supernatant fraction by gradient elution from carboxy-
methyl-cellulose (21). The transferases were identified as transferase AA, A, B, and C. For
some time the nomenclature of Jakoby, which was based on the naming of enzymes
alphabetically in reverse order of their elution from the anion exchanger, was utilized.
However, in 1977 Bass et al. showed that three major classes of glutathione transferase
subunits from rat liver had different apparent molecular weights on sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) (22). Bass called these subunits Ya, Yb, and
Yc in order of increasing apparent molecular weight.
In 1982, Mannervik and Jensen devised a new nomenclature, wherein each subunit
was named by a single letter of the alphabet (23). However, it soon became obvious that
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variants of the transferases in rat were too numerous to be covered by the alphabet.
Consequently, in 1983 during a workshop on the glutathione transferases, researchers agreed
to implement a numerical system. In this system, every subunit receives its own number. The
identification of each transferase is based on the number given to its two constituent subunits.
Table 1 summarizes the nomenclature which is used to identify the transferases. For the
purpose of this text, the nomenclature of Bass et al. will be utilized.
The multifunctional nature of glutathione S-transferase.
The glutathione S-transferases are capable of catalyzing a broad spectrum of
reactions: they are associated with a number of activities in addition to glutathione
conjugation. One is glutathione peroxidase activity towards organic peroxides, such as
cumene hydroperoxides, t-butylhydroperoxide and free fatty acyl hydroperoxides (24,25).
Another is catalysis of glutathione-dependent isomerization (26). Additional reactions
catalyzed by the transferases are the catalytic reactions of glutathione with organic nitrates
and thiocyanates which result in the release of HNO2 respectively. These
substrates are used by the Ya, Yb-|, and Yb2 subunits (27). A fifth glutathione transferase-
catalyzed reaction is formation of S-acetyl glutathione from 4-nitrophenyl acetate by the Ya,
Yb-i and Yb2 subunits (28). Examples of some reactions catalyzed by the glutathione S-
transferases are in Fig. 1.
Another important characteristic of the glutathione transferases is non-enzymic. This
is the binding activity (hence the name ligandin). The transferases have been shown to bind a
number of molecules with lipophilic moieties such as the endogenous ligands haem and
bilirubin. The Ya subunit is very important with respect to binding these endogenous ligands
(29). This subunit also appears unique in its ability to react covalently with photo-activated
-5-
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1-1 Bl YaYa ■-2 27000 9.1
1-2 B2 YaYc BL - 9.1
2-2 AA YcYc B2 30000 9.0
3-3 A YbiYbi A2 28500 8.4
3-4 C YbiYb2 AC - 7.4
4-4 D Yb2Yb2 C2 28500 6.7
5-5 E - - 28500 7.0
6-6 - YnYn - 27800 5.3
7-7 - YpYp
^ ''' Data in this table taken from References 21,22 and 23.
25500 6.8
★
Apparent molecular weight by sodium dodecyl sulphate polyacrylamide gel electrophoresis
(using ovalbumin, carbonic anhydrase and soy bean trypsin inhibitor as standards).
pi determined by isoelectric focusing.
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<•) Conjugation
Fig. 1. Glutathione S-transferase Activities
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bromosulfophthalein, metabdically activated benzo[a]pyrene, and amino azodye carcinogens
(30).
The range of activity of the transferases is reflected by the names that have been given
to these enzymes: nameiy, giutathione S-aikyltransferase, glutathione S-alkenetransferase,
glutathione S-epoxide transferase, glutathione peroxidase, organic nitrate ester reductase,
steroidisomerase, A ^-3-ketosteroid isomerase, ligandin, and phosphoric acid triester-
glutathione alkyltransferase. With the exception of the steroid-designated enzymes and the
peroxidase, all of these activities are now identified as glutathione S-transferase (EC 2.5.1.18.).
Purification
The purified rat liver glutathione S-transferases are homodimers or heterodimers
comprised of at least eight subunits (Ya, Yb^, Yb2, Yc, Yd, Yp, Yk, Yn) which can be separated
by one dimensional SDS-polyacrylamide gel electrophoresis (31-35). The proteins have
molecular weights of about 50,000 daltons and are composed of two subunits of
approximately equal molecular weights.
Most of the glutathione transferases in rat liver are proteins with an alkaline isoelectric
point. Five transferases, AA, A, B, C, and E were purified to homogeneity by Jakoby et al. (35-
38). These transferases are bound to carboxymethyl-cellulose as an early step in their
purification and are named in the reverse order of their elution from the anion exchanger.
Transferases A (38) and B (16) have been crystallized by Jakoby and coworkers. Transferase
B is known to be highly organized with 40% a-helical and 15% beta-pleated sheet character
(39).
Another transferase, designated M, is not bound by carboxymethyl-cellulose and was
purified by Gillham (40) who noted that M binds to diethylamino ethyl-cellulose early in
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purification. This transferase reacts with menaphthyl sulfate.
Askelof et al. have developed a purification method for transferases A and C which
takes advantage of the basic nature of the rat liver transferases (41). More recently, Clark et
al., have utilized affinity methods to isolate transferases in nearly pure form from the greater
wax moth. Galleria mellorella (42). In their procedure, Clark et al., prepared an affinity column
by coupling the thioether of glutathione and bromosulfophthalein to cyanogen bromide
activated sepharose 4B. The transferases were eluted with either glutathione or with
bromosulfophthalein and isolated in nearly pure form.
Isoelectric focusing has high resolving power and has proved useful in the separation
of various isozymes of the glutathione S-transferases. Chromatofocusing has also been very
useful in the separation of rat liver isozymes. Finally, the latest purification schemes have
employed high performance liquid chromatography (HPLC and FPLC), thereby allowing
protein separation in a time span of minutes.
The amino acid composition of transferases AA (39), A (37), B (37) and C (35) have
been obtained by Jakoby et al. This data has lead to the conclusion that transferases A and C
are very similar in gross composition whereas each of the others appear distinct. The
specificity of antibodies produced separately against each of these transferases and against E
are in agreement with this conclusion. Also, the cDNAs encoding the Ya and Yc subunits have
been isolated and indicate that these subunits are similar.
The Human Transferases
Jakoby et al. have identified five glutathione S-transferases from human liver by elution
from carboxymethyl-cellulose, and they are distinguished on the basis of their isoelectric
points (43). All have been purified to homogeneity and are identified by Greek letters
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(a, ,7.5, €) in increasing order of isoeiectric point. Transferasea has the iowest pi, while
transferase e is the most aikaiine. Ali are dimeric proteins of approximateiy 49,000 daltons,
composed of apparentiy identical subunits.
Assay Systems
The most conyenient and sensitiye assay for giutathione transferase actiyity is a
spectrophotometric one in which glutathione and 1-chioro 2,4 dinitrobenzene serve as
substrates (Fig. 2, Equation 1) (35).
Severai spectrophotometric methods have been developed for a variety of
compounds including an unsaturated ketone (trans-4-phenyi-3-buten-one) as substrate, (44),
an epoxide [2-epoxy-3-(p-nitrophenoxy)propane] (36), and a sulfate ester (menaphthyl sulfate)
(40). These reactions are depicted in Figure 2 (Equations 2-4, respectively).
Trimetric methods have also been developed for following the reaction of
iodomethane (45) (Figure 2, equation 5). Also, several investigators have used radioactive
substrates for assays of reactions with oxides (46,47), trisubstituted phosphates (48) and
disulfides (49). Nitrogiycerin as well as thiocyanates may each be used as substrates and may
be foiiowed by measurement of release of nitrite and cyanide, respectively (27).
Endogenous Substrates
Although most of the electrophilic substrates considered so far have been exogenous,
there are severai endogenous substrates for the glutathione transferases. One group of such
substrates, the 4-hydroxy aikenals, are toxic products of fatty acid decomposition produced
during iipid peroxidation (50,51). Another endogenous giutathione conjugate of physiologicai







GSH ♦ ICHj ■ ■ GSCHj ♦ HI (5)
Fig. 2. Reactions Depicting Assays for Glutathione S-transferase Activity
-11 -
Distribution of Rat Liver Glutathione S-Transferase.
1) Subcellular location and site of synthesis.
The early availability of antibody to glutathione S-transferase B allowed for quantitative
estimates of availability of this isozyme, in normal rat liver, 45 nM/mg of soluble protein, in
kidney, 22jLiM/mg, and in small intestinal mucosa, 25/xM/mg (53). At the subcellular level,
transferase B is also found in nuclei (54), microsomal membranes (55,56) and in intra-
mitochondrial matrix space (57).
2) Tissue and species distribution.
In the rat, the liver is the most abundant source of the glutathione S-transferases. The
transferases represent about 10% of the extractable protein of rat liver and can be induced to
greater than 20% (55). Taking the rat as a whole, the Yb2 subunit is the most abundant while
the Ya is most abundant in liver and kidney.
Reports by several investigators suggest that the rat glutathione S-transferases are
expressed in a tissue-specific manner. In 1979, Guthenberg and Mannervik isolated a
transferase from rat lung that was not present in liver (58). A couple of years later, Scully and
Mantle reported that the Ya subunit was absent from testis and that Yb subunit was absent
from kidney (59). Tu et al. used in vitro translation and protein purification tools to study the
differences in expression of the rat glutathione S-transferases in a number of tissues.
Poly(A''')-RNA was isolated from six rat tissues (kidney, lung, liver, heart, spleen and testis)
and translated in vitro using the rabbit reticulocyte lysate system in the presence of ^®S-
methionine. The glutathione S-transferase subunits synthesized in vitro were purified from
translation mixtures by affinity chromatography on S-hexyl glutathione-linked sepharose
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6B columns. The affinity bound fractions were anaiyzed by SDS-polyacryiamide gei
electrophoresis. Using this methodology, Tu et al. identified a transferase subunit (M^ ==
22,000) that was present in heart, kidney, lung, spleen, and testis but was iacking in liver (60).
Pembie et al. (61) have demonstrated that expression of giutathione S-transferase P
occurs in a tissue-specific manner. In effect, mRNA hybridizing to the glutathione S-
transferase P cDNA probe was detected in epididymis, kidney, adrenai gland, lung, spleen,
skeletal muscle and heart but not in testis or normai liver.
Other supporting evidence for tissue-specific expression of the giutathione S-
transferases comes from reports by Li et ai. (62) and more recently by Abramovitz and
Listowsky (63). Li et al. showed that the Ya subunit is not expressed in rat brain and
demonstrated that two distinct transferase subunits (Mr=26,300 and 25,000) were
expressed in brain. Abramovitz and Listowsky isolated and characterized a novel Yb cDNA
(Yb3) clone from a rat brain A gtl 1 expression library and observed that the mRNA was 1300
bp in length and was expressed mainly in brain. This data was the first direct evidence that the
Yb genes are expressed in a tissue-specific manner.
Finally, Hayes and Mantle employed Western blot analysis using polyclonal antibody
to examine the tissue distribution of various glutathione S-transferases, namely the Yp, Yk, Ya,
Yn, Yb and Yc subunits (64). Their data provides additional support at the protein level for
tissue-specific expression of the glutathione S-transferase subunits.
The glutathione S-transferases are found in a wide variety of species including marine
species such as elasmobranch, teleosts, and crustaceans (65), as well as in lower mammalian
species, including ticks, flies, and locusts (17). The transferases are also fourtd in higher
mammals, such as monkey, guinea pig, and rabbit (66,67). Transferase activity is not
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restricted to the animal kingdom; algae (68), higher plants (68), and certain bacteria (69), also
have transferase activity.
Inducers
The concentration of glutathione transferases in tissues is subject to regulation at
several levels. Induction of the transferases has been reported following administration of
phenobarbital (66), tetrachlorodibenzo-p-dioxin (TCDD) (70,71), methadone (72), and various
pesticides (73-75) to experimental animals. The common antioxidant, BHA [2(3)-tert-butyl-4-
hydroxyanisole], which is used by food processors, is an inducer of the transferases in mice
and rats (76). Figure 3 contains the chemical structures of some known inducers of the
transferases.
The Role of Glutathione S Transferase in Detoxification of Xenobiotics
The glutathione transferases have been intensively studied because of their role in the
biotransformation of xenobiotics. The transferases are multifunctional in detoxification. They
are important in the catalysis of reactions in which glutathione acts as a nucleophile: they
serve as binding proteins, storing bilirubin in the liver, and they are capable of forming covalent
linkages with alkylating agents.
Figure 4 depicts a flow scheme of a possible biotransformation of an electrophilic
species after conjugation with glutathione. The reactive electrophile may be any compound
capable of forming a stable conjugate with glutathione. The X represents both the chemical
groups that are eliminated (e.g. halogenides) and those that are modified without elimination
(e.g. epoxides and alkenes). In the reaction catalyzed by the transferases, the S atom of
glutathione (a) provides electrons for nucleophilic attack on the second electrophilic substrate
(b). The newly formed glutathione conjugate (c) may then be excreted as such or hydrolyzed
- 14-
3-HelhyIcholanlhrene p - Naphthof1avone
Benzo(a^pyrene 2,3,7,8-Tetrachlorodiben20-p-dioxin
Phenobarbilal Bulylaled Hydroxyartiso 1e





























4. Metabolic Pathway for the Synthesis of the Mercapturic Acids. The initial step is
catalyzed by the glutathione S-transferases.
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in two steps to an S-(substituent)-cysteine derivative (e). The cysteine conjugate can then be
N-acetyiated with acetyi Co enzyme A to yieid a mercapturic acid or mercapturate (f), which is
a ciassical urinary excretion product of xenobiotics (77).
Rat Liver Giutathione S-Transferase cDNAs.
Recent work on the glutathione S-transferases has focused on elucidating the
mechanism by which the isozymes are regulated in response to xenobiotic administration.
Much of the remainder of this text will focus on how molecular biology approaches have been
used to unravel the complexity of the glutathione S-transferase subunits and their expression.
Many of the studies which will be discussed will focus on the rat enzymes, since they are the
most studied and are the focus of the work of the author.
Several labs have isolated cDNA clones complementary to the Ya, Yb-|, Yb2 and Yc
mRNAs (78-86). DNA sequence analysis of the clones has revealed an overall 66% nucleotide
sequence identity between the Ya and Yc mRNAs and a 75% identity in nucleotide sequence in
the protein coding region of these two mRNAs. Therefore, the Ya and Yc mRNAs and their
corresponding proteins belong to one glutathione S-transferase gene family. The Ya subunit
consists of 222 amino acids with a molecular weight of 25,547, and the Yc subunit is
comprised of 221 amino acids with a molecular weight of 25,322. The sequence data has also
revealed that more than one Ya gene is expressed in rat liver. To date, three full-length or
nearly full-length Ya cDNA clones have been isolated and characterized. Two of the clones
pGTR261 (79) and pGTB38 (80) differ by 15 nucleotides which translates into eight amino acid
differences. The 3' untranslated regions of the two cDNAs are divergent. A third clone,
pGTB45, is more similar to pGTR261 than to pGTB38, thus supporting the idea that the two
clones are derived from distinct mRNAs encoded by separate genes (86). This clone, pGTB45,
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contains a type 2 Alu repetitive element in the 3' untranslated region. The element consists of
two overlapping polyadenylation signals downstream from the polyadenylation signal in
pGTR261. The function of this element is unknown.
DNA sequence analysis of the Yb-| and Yb2 cDNA clones revealed that there is an
84% nucleotide sequence identity over the protein coding region of the two mRNAs (87-90). In
the 3' untranslated region, there is only 32% sequence identity. The amino acid sequences of
the Ybi and Yb2 subunits share an 80% sequence identity. The Ybi polypeptide consists of
218 amino acids with a molecular weight of 25,919; the Yb2 subunit is also comprised of 218
amino acids but has a molecular weight of 25,705. The amino acid sequence of the Yb2
subunit has also been determined directly by conventional protein-sequencing procedures
(91). The sequence of the purified protein agrees with that predicted from nucleotide
sequence analysis of cDNA clones. Lai et al. have published the sequence of a second Yb^
cDNA clone which differs from pGTA/C44 by four nucleotides in the coding region resulting in
two amino acid differences (89). The 5‘ and 3' untranslated regions are identical to those of
pGTA/C44.
More recently, Lai et al. (92) have reported the characterization of a Yb4 cDNA clone
which differs from other Yb cDNA clones by 40 to 53 amino acids. The Yb4 cDNA clone
shares significant homology (40 amino acid substitutions) to the Ybi cDNA clone pGTR200.
There is 70% homology between the two 3' noncoding sequences. These data confirmed the
existence of a second distinct glutathione S-transferase gene gamiiy.
Also noteworthy at this point is a report by Abramovitz and Listowsky on the
characterization of a Yb3 cDNA isolated from a rat brain X gtl 1 expression vector iibrary (63).
This Yb3 was shown to be a major form of transferase in rat brain while existing as a minor
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form in the liver. The cDNA clone has greater than 80% sequence homology with the Ybi and
Yb2 cDNA clones. The amino acid sequence derived for the Yb3 subunit has 28 amino acid
substitutions unique to the Yb3. The 3' untranslated region is totally divergent from all other
isolated transferases.
Suguoka et al. (93) have reported the isolation of a glutathione S-transferase p cDNA
from a library prepared from poly(A''')-RNA isolated from 2-acetylamino fluorene-induced rat
hepatocellular carcinoma. The cDNA encoding the Yp subunit revealed that the Yp
polypeptide is comprised of 210 amino acids with a molecular weight of 23,307. The amino
acid sequence of the Yp subunit was compared to that of the Ya and Yc subunits and was
shown to possess an overall sequence identity of 32%, with homologous amino acids
clustered in three regions of the amino acid sequence. Pemble et al. (61) have also isolated a
cDNA clone, pGSTr7, which is identical to the Yp cDNA isolated by Suguoka et al. (93). This
clone was isolated from a AgtIO library that was constructed from N,N-dimethyi-4-
aminoazobenzene-induced rat hepatoma.
Human Liver cDNA
Recently, Tu and Qian reported the isolation and nucleotide sequence analysis of a
human glutathione S-transferase cDNA clone, pGTHI which encodes a polypeptide of 222
amino acids (94). The nucleotide sequence of the coding region of pGTHI is roughly 80%
identical to the rat liver Ya and Yc clones and the deduced amino acid sequence has 75%
identity to these same two subunits. The human cDNA sequence was found to be
homologous to the rat liver Yb subunits near the NH2 terminal region (amino ackJ residues 70-
95). Interestingly, Tu and Qian found that residues 70-95 are conserved in all the glutathione
S-transferase subunits.
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Structural Analysis Liver Glutathione S-Transferase Genes
The availability of glutathione S-transferase cDNA clones has facilitated the isolation
and characterization of the structural genes, which are essential in elucidating the mechanism
by which the genes are regulated by xenobiotics.
1) The Ya-Yc gene family. In 1986, Telakowski-Hopkins et al. (95) isolated and
characterized a rat liver glutathione S-transferase Ya gene. The Ya gene spans approximately
11 Kb and is comprised of seven exons separated by six introns. Exon 1 is 43 bp in length and
encodes most of the 5' untranslated region of the Ya mRNA. Exon 2 is 109 bp in length and
encodes amino acids 1-29 of the Ya subunit and 22 bp of the 5' untranslated region. Exon 3 is
52 bp and encodes amino acids 30-46 of the Ya polypeptide. Exons 4 and 5 are 133 bp and
142 bp in length and encode amino acids 47-91 and 92-139, respectively. Exon 6 is 132 bp in
length and encodes amino acids 140-183 of the Ya polypeptide. Exon 7 is 234 bp in length
and encodes amino acids 184-222 of the Ya protein and 121 bp of the 3' untranslated region of
the Ya mRNA.
It is interesting to note that the amino acid sequence encoded by exon 3 represents
the region that is most divergent between the Ya and Yc polypeptides. In this region there is
only a 36% amino acid sequence identity between the Ya and Yc polypeptide, whereas there is
an overall sequence identity of 66% between the two subunits. Exons 2 and 4 encode domains
of the Ya subunit that are highly conserved in the Yc polypeptide. The amino acid residues of
the Ya subunit encoded by exons 2 and 4 are 86% and 91% identical, respectively. The
significance of conserved and divergent domains is not known; however, it has been
suggested that the conserved exons encode domains of the subunits that impart similar
functional properties such as glutathione binding site (95). Exons 3 and 5, which encode
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divergent regions, are believed to encode domains of the subunits that are responsible for their
substrate specificities. For example, the Ya subunit has high steroid isomerase activity,
whereas the Yc subunit has high activity towards organic peroxides.
Finally, the precise number of Ya and Yc genes remains unknown. Southern blot
analysis of genomic DNA using 5' and 3' regions of a Ya cDNA clone (pGTB38) indicates the
presence of approximately five Ya genes and two Yc genes. It is unknown whether some of
these genes are pseudo-genes or whether all of them are expressed in the liver. No laboratory
has reported the characterization of a full-length glutathione S-transferase Yc structural gene.
A gene encoding the mouse Ya subunit has been isolated and characterized by Daniel
et al. (96). The gene spans a distance of approximately 11 Kb, contains seven exons
separated by six introns, and encodes an mRNA of 841 nucleotides. Promoter elements,
namely TATA and CCAAT box sequences were located 32 and 70 nucleotides upstream from
the initiation of transcription. The mouse Ya gene produces a 223 amino acid polypeptide that
differs from the 220 amino acid rat Ya gene by 10 amino acid substitutions and a carboxyl
terminus Phe-Lys-lle-GIn instead of Phe-Lys-Phe.
2) The Yp gene family. The structural gene encoding glutathione S-transferase Yp
subunit was isolated recently from a rat liver genomic library by Okuda et al. (97). The gene
spans a distance of 3 Kb and like the Ya gene consists of seven exons separated by six
introns. The start of transcription maps 70 nucleotides upstream from the translation initiation
site.
Okuda et al. (97) have also determined the entire nucleotide sequence of a Yp
genomic clone and have shown that it corresponds in sequence to the previously described
cDNA clone, pGP5 (93). The group also identified several process-type pseudo genes.
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which are believed to have originated by reverse transcription followed by insertion at specific
sites.
3) The Yb gene family. Lai et al. have isolated and characterized a rat liver glutathione
S-transferase Yb2 gene (92). The gene spans a distance of 5 Kb and consists of eight exons
separated by seven introns. The eight exons encode 12, 25 1/3, 21 2/3, 27, 34, 32, 37 and 29
amino acids, respectively. An analysis of this gene will be included later in this text under
Discussion.
Regulation of Glutathione S-Transferases bv Xenobiotics
Several studies have demonstrated that the glutathione S-transferases are elevated in
the livers of rats administered 3-methylcholanthrene and phenobarbital. The increase in
enzyme content and/or activity is paralleled by an elevation in the translational activity of the
Ya, Ybi and Yb2 mRNAs (98,99). Using in vitro translation systems and immunoprecipitation
with Ya specific antibody, an increase in the translational activity of the Ya mRNA was detected
4 hrs after a single administration of phenobarbital. The induction was maximal (five to seven¬
fold) between 16 and 24 hr (100). RNA blot analysis using cDNA clones complementary to Ya
mRNA confirmed that the increase in translational activity of this mRNA was due to an
accumulation in the steady-state level of Ya specific mRNA (101). Using specific regions of the
Ybi and Yb2 cDNA clones in RNA slot blots, it was demonstrated that both of these mRNAs
are also elevated by phenobarbital and 3-methylcholanthrene (101). Subsequently, the
question arose as to whether the accumulation of glutathione S-transferase mRNAs in
response to xenobiotics was due to transcriptional activation of the transferase genes.
Nuclear run off assays were performed to answer this question. For the nuclear run off assays,
nuclei were isolated from the livers of rats treated for various times with either phenobarbital or
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3-methylcholanthrene (102). Using ^^P-UTP as the radiolabel, isolated nuclei were allowed to
complete nascent RNA chains in vitro. P-RNA was isolated and hybridized to various
glutathione S-transferase cDNA clones. The transcriptional activity of the transferase genes
was reflected by the amount of P-RNA that hybridized. The transcriptional rate of the Ya
genes was elevated five-fold at 8 hr after phenobarbital administration, while the Yb gene
activity was elevated four fold at 6 hr after administration of the xenobiotic. With 3-
methylcholanthrene, the transcriptional rate of the Ya genes was elevated eight-fold at 16 hr
after administration of this xenobiotic while the activity of the Yb genes was elevated four-fold
at 6 hr after administration. The extent of transcriptional activity was sufficient to account for
elevation in mRNA levels in response to xenobiotics.
The mechanism by which the glutathione S-transferase genes are transcriptionally
activated in response to xenobiotic administration is unclear. Recent work by Telakowski-
Hopkins et al. (101) has centered on the construction of chimeric genes using 1.6 Kb of 5’
flanking region of a glutathione S-transferase Ya gene fused to the structural gene encoding
chloramphenicol acetyl transferase (CAT). The chimeric gene was transfected into rat, mouse,
and human hepatoma cell lines and the 1.6 Kb Ya fragment directed CAT synthesis. When
cells containing the Ya promoter fused to CAT were treated with /3 -naphthoflavone, a
compound known to bind to the Ah (aryl hydrocarbon) receptor, CAT activity was elevated
three to seven-fold in the hepatoma cell lines (101). When a chimeric gene containing CAT
under the control of the SV40 promoter and enhancer was transfected into these cell lines, no
increase in CAT activity occurred when p -naphthoflavone was added. This data suggested
that the glutathione S-transferase Ya structural gene contained cis-acting regulatory elements
that are responsible for transcriptional activation. The role of the 5' flanking region of the
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glutathione S-transferase Ya subunit was studied further, and two cis-acting regulatory
elements were identified. One regulatory element confers responsiveness tO;9-naphthoflavone,
and the other regulatory element is necessary for maximum basal level expression. In addition
to identifying two key regulatory elements, Telakowski-Hopkins et al. also demonstrated, using
variant mouse cell lines defective in the dioxin receptor, that a functional Ah receptor is
required for responsiveness of the regulatory element to^-naphthoflavone.
Sakai et al. (102) furthered their studies on the rat Yp gene by analyzing the cis-acting
regulatory DNA elements of the gene. Various regions of the 5' flanking sequence of the gene
were fused with the CAT gene and transcriptional activity was determined by the transient
expression assay after introduction into a rat hepatoma cell line, dRLh84. Multiple regulatory
elements were identified. Two enhancer elements were located 2.5 and 2.2 Kb upstream from
the transcription start site. These elements were designated GPEI and GPEII. GPEI contains a
consensus sequence for the phorbol ester (TPA) responsive element and GPEII contains two
of the SV40 enhancer core-like sequences. A silencing element was also found 400 bp
upstream of the cap site. The endogenous Yp gene as well as the exogenously translated
gene were found to be stimulated when the rat fibroblast line 3Y1 was treated with phorbol 12-
0-tetradecanoate 13-acetate (TPA).
The Role of the AH Receptor In the Regulation of Drug Metabolizing Enzymes.
In the cytochrome P-450 system, Whitlock and colleagues (103-105) have shown that
the Pi -450 gene, the major 3MC Inducible isozyme, contains a core promoter, dioxin
responsive element, and a negative regulatory element that interacts with a repressor protein.
Similar observations have been reported by Gonzalez and Nebert (106) and Fujisawa-Sehara
et al. (107). Dioxin responsive elements (DREs) have also been identified upstream in the rat
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(p450c) and human (p450) genes that correspond to the mouse P-j -450 by Sogawa et al.
(108). Sogawa et al. (108) have deduced a consensus sequence 5'GNTAGCTCGGGG
G 3' which is beiieved to form part of the dioxin-responsive element. Whitlock and colleagues
have also devised a model to account for the regulation of the P-j -450 gene by polycyclic
aromatic hydrocarbons (105). In the model, the AH or dioxin receptor binds polycyclic
aromatic hydrocarbons, forming a receptor ligand complex that is translocated to the nucleus
and interacts with a positive regulatory element. This interaction results in the transcriptional
activation of the P-| -450 gene. Currently, it is unclear whether the AH receptor is directly or
indirectly involved in the induction of glutathione transferase genes. Studies on the regulation
of the transferases are aimed at determining whether this model accounts for transcriptional
activation of these genes.
METHODS
Plating and Transferring of Genomic Library
One million plaques from a rat liver Haelll genomic library cloned into A Charon 4A
were screened using a modification of the Benton and Davis procedure (109). The library was
titered using serial dilutions and plated at a density appropriate for screening. The library was
diluted to 2000 pfu/^l in SM (50 mM Tris pH 7.5,100 mM NaCI, 13 mM MgS04, plus 2%
gelatin). The plating bacteria were prepared by inoculating a single colony of E cgL' LE392
into 50 ml of NZCYM (1% NZ amine, 0.1% casamino acids, 0.5% bacto-yeast extract, 85 mM
NaCI, 13 mM MgS04) media supplemented with DT (0.2% maltose 0.1% diaminopimelic acid,
and 0.04% thymidine) and incubating at 37“ C overnight with shaking. The bacteria were
collected by centrifugation at 4000 rpm for 10 min at room temperature. The pellet was then
resuspended in sterile 0.01 M MgS04 [(0.4 x volume of original culture) or A0OO = 2].
An aliquot (25/il) of the library dilution (containing 2000 pfu/^l) was mixed with 0.25
ml LE392 plating bacteria and incubated at 37° C for 20 min. Following incubation 6.5 ml
molten (55° C) NZCYM+ DT top agarose was added, mixed by inverting, and poured onto
prewarmed 15 cm NZCYM + bottom agar plates. (Top agarose is 0.7% agarose; bottom agar
is 1.5% agar)
The plates were incubated at 37° C for 15 hr or until minute plaques were visible.
Plates were then chilled at 4° C for 4 hr in preparation for plaque lifts. Nylon filters were gently
placed on the plates and the plates and filters were keyed with India ink. After 2 min the filters
were gently pealed from the agarose, placed in 0.5 M NaOH for 3 min, and then placed on dry
Whatman paper for 2 min. The NaOH treatment was repeated and the filters were again
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placed on dryWhatman paper for 2 min. The filters were then neutralized in 1 M Tris-HCI, pH
t
7.5 for 5 min and allowed to air dry.
Plague Hybridization
The glutathione S-transferase Ybi cDNA clone, pGTA/C44, was utilized to prepare a
^^P-labeled probe to screen the plaques. The ®^P labeled probe was prepared by nick
translation of the plasmid DNA according to the method of Rigby et al. (101). To one
microgram of plasmid pGTA/C44 was added 0.2 mMadATP, 0.2 mMadGTP, 0.2 mMadTTP,
500 mM Tris-HCI (pH 7.8), 50 mM MgCI2,100 mM^ mercaptoethanol, lOO/Lig/ml nuclease
free bovine serum albumin, and 200^01 ofa^^P dCTP. The reaction was initiated by the
addition of 100 U of DNA polymerase I/DNase I and was incubated at 15° C for 60 min. The
reaction was stopped by the addition of EDTA to 30 mM. The labeled DNA was separated
from the nucleotides by subjecting the reaction mixture to gel filtration on an Sephadex G-75
(or ACA-54) column which was equilibrated with 10 mM Tris-HCI, pH 8.0/2 mM EDTA.
Fractions (0.5 ml) were collected and those containing the peak of radioactivity were pooled
and utilized for the hybridization.
The nylon filters, containing the fixed DNA, were pre-hybridized at 42° C for 6 hrs in
50% deionized formamide, 10% SDS, 1 M NaCI, 10% dextran sulphate, and 100/ig/ml salmon
sperm DNA. Following pre-hybridization, a total of 4 x 10® cpm/ml pre-hybridization mix of
pre-boiled P-cDNA probe was added, and the filters were incubated overnight at 42° C. The
filters were then washed In 2 x SSC (0.15 M NaCI, 0.015 M Na citrate, pH 7.0.) at room
temperature for 15 min, in 2 x SSC/1% SDS at 65° C for 60 min, and in 0.1 x SSC at room
temperature for 20 min. The filters were air dried and exposed for autoradiography.
Putative positive plaques were selected by aligning master plates to the
autoradiogram. Plaques corresponding to the center of positive signals were picked using a
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sterile pasteur pipette. Plugs were expelled into 1 ml SM containing a drop of chloroform.
Putative positive plaques were subjected to 3 additional cycles of screening until a 100%
positive response was achieved, indicating plaque purity. Plaque plugs were amplified by
plate lysis and stored at 4° C in the presence of chloroform.
Large Scale Preparation of Phaoe DNA
Phage DNA was isolated from the positive plaques using a modification of the
Yamamoto procedure for plate lysis (111). Phage were plated (at a density of 10^ pfu/150 mM
plate) as described previously under plating of the genomic library. Plates were incubated
overnight at 37° C and then chilled for 2 hr at 4° C. Following addition of 12 ml SM per plate,
the plates were placed at room temperature on a shaker for 6 hr. Lysates were collected and
pooled. To the lysates, NaCI (15 g/250 ml) was added and dissolved by rotating samples for
30 min at room temperature. This was followed by addition of polyethylene glycol (25 g/250
ml lysate) and continuous rotation at room temperature for 30 min. Lysates were then
incubated at 4° C and rotated overnight. The phage lysates were then subjected to
centrifugation at 4000 rpm for 15 min at 4° C and the pellet resuspended in 2 ml SM. The
precipitate was extracted with 2 ml CHCI3 and spun for 20 min at 6000 rpm at 4° C. The
supernatant was collected and the volume adjusted to 3 ml by adding 5.6 M CsCI. The phage
lysate was layered onto a CsCI step gradient containing 3.6 M, 4.0 M, and 5.6 M CsCI. The
gradient was centrifuged in an SW-40 rotor at 30,000 rpm for 2.5 hr at 20° C. The phage DNA
band (bluish-purple) was extracted and mixed with 0.1 volume of 200 x TE in a siliconized
corning tube. One volume of deionized formamide was added and the mix was allowed to sit
at room temperature for 30 min. One volume of H2O was added, followed by addition of 6
volumes 100% EtOH. After mixing, phage DNA was precipitated for 5 min at room
temperature and collected by centrifugation at 8000 rpm for 10 min. The pellet was
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resuspended in 2 ml TE. The phage DNA was then treated with tOO/ig RNase A, incubated at
37° C for 10 min, and treated with 20% SDS plus 400/xg proteinase K. The DNA was
incubated at 65° C for 30 min, allowed to cool to room temperature, extracted twice with TE
saturated phenol:CHCl3:IAA (50:24:1), and extracted 3 x with TE-saturated ether. Phage DNA
was precipitated by addition of 3 volumes of 100% EtOH and collected by centrifugation at
8000 rpm for 15 min at 20° C. The DNA pellet was dried under a gentle stream of N2 and
resuspended in TE.
Southern Blot Analysis
Fragments harboring sequence(s) complementary to regions of pGTA/C44 were
identified by Southern Blot analysis (112). Genomic DNA was subjected to restriction
digestion and fractionated on a 1% agarose gel in 1 x TAE (40 mM Tris-OH/20 mM acetic
acid/2 mM EDTA) in the presence of 0.5/x 9/^1 ethidium bromide. The DNA was depurinated
by incubating the agarose gel in 0.25 M HCI for 15 min at room temperature. Neutralization
was achieved by incubating the gel in 1.5 M NaCI/0.5 M Tris-HCI, pH 7.5 for 30 min at room
temperature with shaking. The gel was then placed on a wick pre-soaked (in SSC) in a gel
electrophoresis unit. A nylon filter, pre-soaked in SSC, was placed over the gel, followed by
addition of two pre-soaked Whatman 15 x 13 cm papers. Blotting paper was stacked over the
Whatman paper and a 1 kg weight was placed atop this fixture. DNA was allowed to transfer
region contains the element(s) overnight in SSC. Following transfer the filter was removed and
immersed in 0.4 M NaOH for 60 sec to ensure complete denaturation of the immobilized DNA.
The filter was then neutralized in 0.2 M Tris-HCI, pH 7.5/2 x SSC for 3 min and air dried.
The dried filter was subjected to prehybridization for 4 hr at 42° C in a mix containing
50% formamide, 1% SDS, 1 M NaCI, 10% dextran sulphate and 1 /xg/ftil salmon sperm DNA.
DNA fragments containing the 5', middle and 3' regions of the glutathione S-transferase Yb-|
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cDNA clone pGTA/C44 were utilized as radiolabeled probes as in the screening. A total of 4 x
10® cpm of radiolabeled probe was added and the hybridization was continued at 42° C
overnight.
The filter was washed in 2 x SSC for 15 min at room temperature, in 2 x SSC/1% SDS
for 30 min at 65° C, and in 0.1 x SSC at room temperature for 10 min. The filter was then air
dried and exposed for autoradiography.
Isolation and Purification of DNA Restriction Fragments from Agarose Gels
Clones which harbored sequences complementary to the 5', middle, and 3' regions of
pGTA/C44 were digested with the appropriate restriction enzyme (EcoRI) and the DNA was
fractionated on a 1 % agarose gel in TAE in the presence of 0.5 ju g/ml ethidium bromide. The
inserts of interest were visualized under UV light and excised using a razor blade. Gel slices
were placed in microfuge tubes and the agarose dissolved by the addition of Nal and
incubation at 37° C for 60 min with intermittant vortexing. Once the agarose was dissolved,
glass agarose beads were added and the mix was incubated with rotation at 4° C overnight.
Beads containing DNA were collected by centrifugation at 15,000 rpm 2 min at 4° C. The
beads were rinsed 2 x in pre-chilled, recrystallized Nal and 2 x in 50% EtOH. Foilowing
centrifugation the beads were resuspended in 100/i ITE, and incubated at 37° C for 60 min.
The supernatant was collected following centrifugation at 12,000 rpm for 5 min and stored on
ice while the pellet was again resuspended in 100/il TE and re-incubated at 37° C for 60 min.
The supernatant was collected after centrifugation and pooled with the first elution. The DNA
was precipitated by addition of 0.1 volume of 3 M NaOAc, pH 7.0 and 2 volumes of 100% EtOH
and incubated on dry ice/EtOH for 15 min. The precipitate was spun at 15,000 rpm for 10 min
at 4° C. The supernatant was removed and the pellet dried and resuspended in 60/il TE. To
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this was added 12/il of 3 M Tris, pH 8.0 and 2 volumes of isopropanol. The DNA was
reprecipitated on dry ice/EtOH 10 min, rinsed with 85% EtOH, dried, and resuspended in H2O
for short term storage or TE for long term storage.Subclonina of Genomic Fragments
The eluted Ybi genomic fragments were inserted into the plasmid vector pBr325.
Chimeric plasmids were prepared by annealing 1 fig EcoRI digested dephosphorylated
pBr325 to 0.5 fig of purified genomic fragment in the presence of 25 mM Tris-HCI (pH 7.8), 10
mM MgCI2, 4 mM B-mercaptoethanol, and 0.4 mM ATP. One unit of T4 DNA ligase was added
and the reaction mixture was incubated at 4° C overnight.
Annealed chimeric plasmids were utilized to transform E. coli HB101 which were made
competent by calcium chloride/heat shock treatment (113). Transformants were piated on L-
agar plates containing 15/iig/ml tetracycline. Positive clones were identified as those clones
which were viable on plates containing tetracycline but not viable on plates containing
chloramphenicol.
Large Scale Plasmid Isolation
Colonies which were viable on L-tet plates but not viable on L-cam plates were sized
by electrophoresis of a small quantity of EcoRI digested plasmid DNA from the colonies (114).
The DNA was fractionated on a 1% agarose gel as described previously. Colonies whose
inserts appeared to be of the expected size were grown on a large scale and the plasmid DNA
was isolated. A single colony of the desired clone was Inoculated into 100 ml L-broth
containing 15 fig/ml tetracycline and incubated at 37° C overnight. The overnight culture
was diluted 1:50 into M9 (18.7 mM NH4CI, 423 mM Na2HP04, 21.7 mM KH2PO4, 85 mM NaCI,
2% casamino acids, 0.4 mM MgS04,0.1 mM CaCl2,0.2% glucose, 10 mg/ml B1 containing
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1 mg/ml uridine). The culture was incubated at 37° C until the optical density at 550 nM was
0.7-1.0. Spectinomycin (300 n g/ml) was added to the culture and incubation was continued
overnight. Bacterial cells were collected by centrifugation at 5000 rpm for 10 min at 4° C,
resuspended in 50 mM Tris-HCI, pH 8.0/25% sucrose and lysed by addition of 10 mg/ml
lysozyme. The cells were placed on ice for 15 min with intermittent agitation, 0.25 M EOTA, pH
8.0 was added and the suspension was again incubated on ice for 5 min. Brij solution (1% Brij-
58, 0.4% Na deoxycholate, 62.5 mM EDTA, 50 mM Tris-HCI, pH 8.0) was added and the
suspension was again placed on ice for 15 min with occasional mixing. The cellular debris was
pelleted at 35,000 rpm in a Beckman 50.2 rotor for 40 min at 4° C. Ethidium bromide (500
fjL g/ml) was added to the lysate and the refractive index was adjusted to 1.3940 with CsCI (0.8
g/ml). The lysate was cleaned by centrifugation at 12,000 rpm for 15 min at room
temperature.
The DNA was isolated by centrifugation at 42,000 rpm in a Beckman 50.2 Ti rotor for
48 hr at 20° C. The band containing plasmid DNA was collected and the refractive index
adjusted to 1.390 with CsCI. The DNA was again centrifuged at 42,000 rpm in a Beckman 70.1
Ti 48 hr at 20° C. The plasmid DNA was then collected, extracted 4 x with CsCI-saturated
isopropanol, and dialyzed overnight in TE, pH 7.8. The plasmid DNA was extracted with an
equal volume of phenohCHClsilAA (50:24:1). The aqueous phase was extracted 3 times with
an equal volume of TE-saturated ether, and the DNA was precipitated at -20° C overnight by
the addition of 0.1 volume of 3 M NaOAc, pH 7.0 and 2 volumes of 100% EtOH. The DNA was
pelleted at 12,000 rpm in a Sorvall SS-34 for 45 min at 4° C, and resuspended in TE.
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Oliaonucleotide Synthesis and Purification
The oligonucleotides used in DNA sequence analysis were synthesized by standard
cyanoethyl chemistry on a Biosearch Model 8600 DNA synthesizer (115). The DNA was
synthesized in the 3'—5’ direction with the first nucieotide bound to controlied pore glass in a
prepacked reaction column.
The synthesis cycle included four major steps. First, the support bound 5' - DMT
(dimethoxy trityl) group (located in a prepacked reaction column utilizing derivatized
controlled pore glass as solid support) was removed with dichloroacetic, acid-generating a
free 5‘-OH for coupling. In the next step, the 5' OH was treated with a mixture of amidite and
activator (1 H-tetrazole) resulting in the formation of a new phosphorus oxygen bond and
thereby increasing the length of the oligonucleotide by one base unit. The third step was
oxidation of the phosphorus (III) to phosphorus (V), a more stable oxidation state. This was
necessary to prevent the dichloroacetic acid used in the deblocking from breaking the
phosphorus (III) - oxygen bond. Finally, a capping procedure was utilized to block the
untreated 5'-OH groups from any further reactions (See Figure 5).
At the conclusion of the synthesis, ammonium hydroxide was used to cieave the newly
synthesized polynucleotide from the support and to remove the phosphoryl (cyanoethyl)
protecting groups. The cleaved oligonucleotide was then incubated at 55° C for 5 hr to
remove the protecting groups, dried under vacuum, and resuspended in 60% formamide, 10/il
xylene cyanol. The oligonucleotide was then heat denatured, loaded onto a 12% acrylamide/8
M urea gel, and electrophoresed until the xylene cyanol reached 12 cm. The gel was removed,
overlayed onto Saran Wrap, and placed on a thin layer chromatography plate. The bands





CPG= controlled pore glass
DMT= dimethoxytrityl
B= base
R= CNCH2CH2-for beta cyanoethyl
+ TETRAZDLE
Fig. 5. Amidite Synthesis Cycle
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through a syringe in 5 mi eiution buffer (0.5 M NH4OAC/10 mM MgOAc, 1 mM EDTA). The gei
siices in the eiution buffer were placed on a shaker overnight at room temperature. The mix
was then further purified by applying it to a Sep Pac column which was pre-equilibrated with 5
ml of 40% acetonitrile and washed with H2O. Pressure was applied using a stream of N2. the
effluent was collected and re-applied to the column. The column was then washed 3 x with 5
ml H2O and the DNA eluted with 4 ml 40% acetonitrile. The mix was iyophilized in a speed vac
and resuspended with 1 ml H2O. The DNA was quantitated by reading the O.D. 260 nM. The
concentration was adjusted to 10 ng//il for use in sequencing.
Nucleotide Sequence Analysis
Plasmid DNA was further purified for sequence analysis by PEG precipitation. The
DNA was incubated for 20 min on ice in NaCi plus 7.5% polyethylene glycol. The DNA was
pelleted by centrifugation at 15,000 rpm for 15 min at 4° C. The pellet was rinsed with 70%
EtOH, dried under vacuum, and resuspended in TE.
Supercoiled plasmid (2/Lig) was resuspended in H2O to 20mI- To this mix, 2/il of 2 M
NaOH/2 mM EDTA was added and the mixture incubated at room temperature for 5 min. The
mix was neutralized by the addition of 0.1 volume of 3 M NaOAc, pH 5.0 and the DNA was
precipitated in 2.5 volumes of 100% EtOH. The pellet was rinsed with 70% EtOH, dried under
vacuum and resuspended in H2O.
For the sequencing reactions, two major systems were evaluated and modified for
optimum results. The first was the Gem Seq K/RT sequencing system by Promega Biotec
(Madison, Wisconsin) and the second was the Sequenase system by United States
Biochemical (Cleveland, Ohio). For both systems, supercoiled DNA was purified, denatured,
and neutralized as described above. Following neutralization, the purified denatured
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template was annealed to the appropriate primer (synthetic oiigonucleotide) and sequenced
by standard dideoxy methodologies (116).
For the Gem Seq system, employing reverse transcriptase, the denatured template
was resuspended in 34 mM Tris, pH 8.3, 50 mM NaCI, 0.5 mM MgCl2. 5 mM DTT. (volume = 7
Atl), mixed with 30 ng of primer (3^l of 10 ng//il stock), and incubated at 37° C for 1 hr. Chain
elongation was accomplished by addition of 5 units of reverse transcriptase plus 4/il ofa P
dATP (800 Ci/mmol) to the annealed primer/template. At this point, 3 /il of the label
a PATP)/primer/template (mix was added to each of the four dideoxy nucleotide mixes and
incubated at 42° C for 20 min. The formulation for the nucleotide mixes are listed in Table 2.
Following incubation, 1 /il of chase solution (2 mM dATP, 2 mM dTTP, 2 mM dGTP, 2 mM
dCTP in 34 mM Tris-HCI, pH 8.3, 50 mM NaCI, 6 mM MgCl2, 5 mM DTT) was added to each
mix and the 42° C incubation was continued for another 15 min. The reactions were stopped
by adding 5/^1 of the stop solution (95% formamide, 20 mM EDTA, 0.05% bromophenol blue,
0.05% xylene cyanol). The reaction mixtures were heat denatured at 90° C for 2 min, and
loaded onto a prewarmed 6% acrylamide/8 M urea sequencing gel and subjected to
electrophoresis in TBE (TBE = 89 mM Tris OH, 89 mM boric acid, 2 mM EDTA).
The Gem Seq system was also utilized with Klenow. The procedure is similar to the
reverse transcriptase procedure with few modifications. For the annealing reactions, the
Klenow buffer consisted of 10 mM Tris-HCI, pH 7.5, 50 mM NaCl2. The formulations for the
Klenow nucleotide mixes are in Table 3 and Table 4. For reactions including Klenow, the chain
elongation was carried out at 37° C.
For the Sequenase system, the denatured template was annealed to 10 ng primer in
sequenase buffer (40 M Tris-HCI, pH 7.5, 20 mM MgCl2, 50 mM NaCI) by first heating the
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ddGTP 50/iM - - -
ddATP - 3.6/iM - -
ddTTP - - 200 mM -
ddCTP - - - lOO^M
dGTP 250mM 250/xM 250 mM 250/xM
dATP - - - -
dTTP 250 jUM 250 juM 250mM 250/xM
dCTP 250mM 250mM 250mM 250/xM
*According to Promega Biotec Technical Manual, (Promega Biotech, Madison, Wl) all nucleotide
mixes contained 34 mM Tris-HCI pH 8.3, 6 mM MgCl2, 50 mM NaCI, and 5 mM DTT.
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Table 3. Gem Seq K/RT System Klenow Nucleotide Mix Formulations*
Component Nucleotide Mixes
G A I
ddGTP 66mM - - -
ddATP - 300mM - -
ddTTP - - 117/xM -
ddCTP - - - 66mM
dGTP 1.66)LiM 33mM 33mM
dATP - - - -
dTTP 33mM 33/xM 1.66mm 33mM
dCTP 33/xM 33mM 33mM 1.66mM
‘According to Promega Biotec Technical Manual (Promega Biotech, Madison, Wl) all nucleotide
mixes contain 10 mM Tris-HCI (pH 7.5), 50 mM NaCI, 10 mM MgCl2, 1 mM DTT.
Table 4. Modified Klenow Nucieotide Mix Formulations
Component Nucleotide Mixes
Q A I
ddGTP 100/xM - - -
ddATP - 20mM - -
ddTTP - - 200mM -
ddCTP - - - 100mM
dGTP 5.4 nM 37.5mm 54m M 54mM
dATP - - - -
dTTP 54nM 37.5mm 5.4mM 54m M
dCTP 54m M 37.5mM 54mM 5.4mM
*Nucleotide mixes contained 10 mM Tris-HCi (pH 7.5), 50 mM NaCI, 10 mM MgCl2,1 mM DTT.
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mix (total volume = 10/jI) 3 min at 65° C, then allowing the mixture to slow cool to below
30° C in a 65° C H2O bath. To the annealed primer/template mix was added 10 mM DTT, 2/il
labeling mix (1.5/iM dGTP, 1.5mM dTTP, 1.5 mM dCTP), 2.5Atl^^P dATP (800 Ci/mmole) or
oc
S-dATP (800 Ci/mmole), and 0.5 units of sequenase. The mixture was incubated at room
temperature for 10 min and 3.5pi of the label/primer/template mix was added to 3pl of each
dideoxy termination mix. The formulations for the termination mixes are in Table 5. The
reactions were incubated at 37° C for 10 min and stopped by addition of 5pi stop solution.
The reaction mixtures were heat denatured and subjected to gel electrophoresis as described
above in the Gem Seq procedure.
Isolation and Purification of Total RNA
Total RNA was isolated by the method of Chirgwin (117). Male Spraque-Dawley rats
were injected intraperitoneally with 40 mg/kg body weight of 3MC. The rats were sacrificed at
16 hr post-injection and livers were obtained. The livers were washed in ice cold saline and all
connective tissue was removed. The livers were minced using a sterile razor blade and
homogenized in 4 M guanidine thiocyanate/0.5% sodium lauroyl sarcosine/0.025 M Na
citrate/0.1 M ^ -mercaptoethanol. Homogenates were centrifuged at 8,000 rpm for 10 min at
10° C in a Sorvall SS-34. The supernatant was decanted and the nucleic acids were
precipitated at -20° C overnight by addition of 0.035 volume of 1 M acetic acid and 0.75
volume of 100% EtOH. The nucleic acid was pelleted as above and dissolved in 7.5 M
guanidine hydrochloride/0.025 M Na citrate/5 mM DTT. The RNA was reprecipitated at -20° C
overnight by addition of 0.025 volume of 1 M acetic acid and 0.5 volume of 100% EtOH. The
RNA was pelleted and reprecipitated as above. The pellet was then rinsed with EtOH,
dissolved in sterile H2O and precipitated at -20° C overnight with 0.1 volume of 2 M KAc pH 5.0
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Table 5. Nucleotide Mix Formuiations for the Sequenase System*
Q A I 5
ddGTP 8/xM - - -
ddATP - 8/xM - -
ddTTP - - 8/xM -
ddCTP - - - 8/xM
dGTP SO/xM 80/xM 80/xM 80/xM
dATP SO/xM 80/xM BOfiM 80/xM
dTTP 80/xM 80/xM 80/xM 80axM
dCTP 80/xM 80/xM 80/xM 80/xM
*According to Technicai Builetin, United States Biochemical, Cleveland, Ohio.
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and 2 volumes 100% EtOH. The RNA was collected by centrifugation at 10,000 rpm for 30
min, dissoived in 5 ml sterile H2O, and frozen at -70° C.
QliaofdTI-Cellulose Chromatography
Poly(A''')-RNA was isolated using affinity chromatography on oligo(dT) cellulose (118).
Total RNA was heated at 68° C for 5 min and cooled to room temperature on ice. An equal
volume of 20 mM Tris-HCI, pH 7.5/1% SDS/2 mM EDTA/1 M LiCI was added to the RNA and
the mixture was applied to an oligo (dT)-ceiiulose affinity column which was equiiibrated in 10
mM Tris, pH 7.5/0.5% SDS/1 mM EDTA/0.5 M LiCi. The column was rinsed with the same
buffer. The poly(A"'’)-RNAwas eluted with 10 mM Tris-HCI, pH 7.5. Fractions containing the
RNA, as determined by absorbance at 260 nM, were pooled and the RNA was precipitated with
0.1 volume of 2 M KAc pH 5.0 and 2 volumes of 100 EtOH at -20° C overnight. The RNA was
collected by centrifugation at 12,000 rpm and the pellet dissolved in sterile H2O.
Primer Extension Analysis
The transcription start site was determined by primer extension analysis (119). An
oligonucleotide primer (5' CCC-AGT-ATC-ATA-GGC-ATG-GTT-CTG-GCG-CTG-TGG 3’), which
represents a 33 bp fragment compiementary to the 5' region of the glutathione S-transferase
Ybi mRNA was synthesized, purified as described previously, and labeled at the 5' end with
7 PdATP. Briefly, 1500 ng of the oligonucleotide was mixed with kinase buffer, (10 mM
MgCi2 5 mM DTT, 50 mM Tris HCI, pH 2.5, 0.05 mg/ml BSA), [7^^P-ATP], pius 10 units of T4
polynucieotide kinase, and the mixture was incubated at 37° C for 30 min. The kinase was
inactivated by heating the reaction mix at 65° C for 5 min. The ^^P-labeled oiigonucleotide
was precipitated by addition of 0.1 volume of NH4OAC plus 10 volumes of 100% EtOH, in a dry
ice bath for 30 min. The DNA was peiieted by centrifugation for 15 min at 15,000 rpm.
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resuspended in H2O, and reprecipitated twice as above. The DNA was then resuspended in
0.3 M NaOAc and quantitated by scintiiiation counting.
A total of 5 X 10^ counts of labeled oligo was added to 30 m 9 poly(A'‘‘) RNA. The salt
concentration was adjusted to 0.3 M NaOAc, 2.5 volumes of 100% EtOH added, and the mix
precipitated as above. The DNAiRNA hybrid was dried by inverting on a Kim wipe for 30 min,
resuspended in 30/il hybridization buffer (80% deionized formamide, 40 mM PIPES, pH 6.4,
400 mM NaCI, 1 mM EDTA) and incubated at 30° C overnight. The DNA:RNA hybrid was
precipitated as above, spun at 15,000 rpm for 15 min, and rinsed with 75% EtOH/25% 0.1 M
NaOAc, pH 5.3. The pellet was dried as above and resuspended in twenty-five microliters of
reverse transcriptase (RT) buffer containing 50 mM Tris HCI, pH 8.0, 5 mM MgCl2, 5 mM DTT,
50 mM KCI, 0.5 mg/ml BSA 0.6 mM dNTPs, (dATP, dCTP, dTTP, dGTP), plus human placental
ribonuclease inhibitor.
Reverse transcriptase (40 units) was added and the reaction mix incubated at 42° C
for 2 hr. The reaction was stopped by addition of EDTA to 40 mM. Next, 50 /i g ribonuclease A
were added and the mix incubated at 37° C for 30 min. The mix was extracted with an equal
volume of phenoliCHCls:IAA (50:24:1). The aqueous phase was transferred to a fresh tube,
and the RNA was precipitated by addition of 3 volumes 100% EtOH, rinsed in 70% EtOH, and
dried under vacuum. The pellet was resuspended in 3 /i ITE plus 4 /x I formamide loading
buffer, boiled for 3 min, and quick cooled on ice. A 3/^1 aliquot was run on a 12%
polyacrylamide/8 M urea sequencing gel. A sequence mix of Ml3mpl9 was run alongside the
extended primer in order to provide a size marker.
DNA Amplification Using Polymerase Chain Reaction
A new technique which allows in vitro amplification of DNA, called the polymerase
-43-
chain reaction (PCR), was utiiized for generating a series of Yb^ promoter deletions (120,121).
The ampiified fragments were subsequently Inserted in the reporter vector, pSVqCAT, a
plasmid vector, containing the structurai gene encoding chioramphenicoi acetyl transferase
(141).
The success of the polymerase chain reaction is based on the thermai stabiiity of Tag
polymerase, an enzyme isolated from Thermus aauaticus. PCR amplification involves the use
of two oligonucleotide primers that flank the DNA segment which will be amplified, and
repeated cycles of heat denaturation of the DNA, annealing of the primers to their
complementary sequences, and extension of the annealed primers with the Tag polymerase.
The primers hybridize to opposite strands of the target sequence and are oriented so that DNA
synthesis by the polymerase extends across the region between the primers (see Figure 6).
Since the extension products are complementary to and capable of binding to the primers,
each successive cycle doubles the amount of DNA synthesized in the previous cycle. The net
result is exponential accumulation of the target fragment at a rate of 2^^, where n is the number
of cycles.
To generate the DNA fragments containing the Yb-] promoter region, the clone
containing the 1.9 Kb EcoRI/Bglll fragment representing the Ybi 5' flanking region, was utilized
as the template for all amplifications. The oligonucleotides were designed with a Hind III
restriction site on the 5' end to facilitate cohesive-end ligations. It was determined that an
additional 4-5 bases on the 5‘ end were necessary for successful restriction enzyme digestion
of amplified fragments. The additional nucleotides chosen at random were TGACG.
For the reactions, the template (15 ng) was mixed with 1 m 9 of each of the designated
oligonucleotides (5‘ end and 3‘ end), 0.2 mM dATP, 0.2 mM dTTP, 0.2 mM dGTP and 0.2 mM
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Fig. 6. Polymerase Chain Reaction
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dCTP, in presence of reaction buffer (10 mM Tris-HCI, pH 8.3, 50 mM KCI, 1.5 mM MgCl2,
0.01% gelatin). The mixture was overiayed with 100/il sterile mineral oil to prevent sample
evaporation, and heated for 3 min at 94° C to inactivate nucleases and proteases. After quick
cooling one minute on ice, 0.5 units of Taq polymerase was added and the cycle of
incubations initiated using a preprogrammed Zymark model MRK-15 robot with 3 heating
blocks. The PCR cycle consisted of 3 incubations: 2 min at 94° C for denaturation, 2 min at
58° C for annealing (oligo to template), and X min at 72° C for elongation. The value for X was
determined by dividing the total length of the DNA to be amplified (base pairs) by 200 (the
number of bps/min polymerase extends) and adding an additional minute to ensure optimum
elongation. The reaction efficiency was monitored by subjecting an aliquot of the product to
agarose gel electrophoresis. A total of 12 different fragments were generated using the PCR
technique ranging in size from approximately 70 bps - 2000 bps.
Construction of Ybi -pSVO CAT Chimeric Genes
One clone, pGTA 1.9 CAT was generated by inserting the EcoRI/Bglll 2 Kb fragment
into pSVqCAT. This fragment hybridized to the 5' end of the Yb-] cDNA clone pGTA/C44, and
contained the putative promoter. The overhang generated by the enzymes was filled in using
the Klenow fragment (122). The fragments were annealed using T4 DNA ligase and
transformed intoE^i HB101. Another clone, pGTA 1.9 CATB, was generated by digesting
pGTA 1.9 CAT with Sacll, subjecting the linearized clone to digestion with Bal-31 exonudease,
filling in overhangs with Klenow, and re-ligating the shortened clone in presence of T4 ligase.
Briefly, 10 ju g linearized pGTA 1.9 CAT was incubated for one minute at 30° C in the presence
of 20 mM Tris HCI pH 8.0, 0.6 M NaCI, 12.5 mM MgCl2,12.5 mM CaCl2 and 3 units of Bal-31
nuclease "fast" form. The reaction was stopped by adding EDTA to 50 mM.
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The amplified DNA fragments were subjected to restriction enzyme (Hindlll) digestion,
extracted with phenol:CHCl3:IAA (50:24:1), precipitated in 0.1 volume of 3M NaOAc plus 2
volumes of 100% EtOH, rinsed with 70% EtOH, spun at 15,000 rpm for 15 min and the pellet
dried under vacuum. The DNA pellet was resuspended in water, and approximately 0.5 m g of
the purified fragment was mixed with 1 /xg linearized (with Hindlll), dephosphorylated
PSVqCAT. The fragment was annealed to the vector as described previously. The chimeric
plasmid was then transformed into competent SCSI cells (Stratagene). The transformation
procedure was modified to yield approximately 1000 transformants. SCSI cells were
incubated in presence of/3-mercaptoethanoi for 10 min on ice. To this mix was added
approximately 250 ng of chimeric plasmid. The mixture was incubated on ice for 30 min, heat
shocked at 42° C for 1 min and cooled on ice for 2 min. The cells were allowed to propagate
in the presence of 0.7 ml of S.O.C. (2% bactotryptone, 0.5% yeast extract, 10 mM NaCI, 2.5
mM KCI, 10 mM MgCl2,10 mM MgS04, and 20 mM glucose) media by incubating at 37° C
with shaking (225 rpm) for 1.5 hrs, the transformants were plated on L-agar plates containing
100 /xg/ml ampicillin.
Clones containing desired inserts were identified by fractionating a small quantity of
Hind HI digested plasmid DNA from the colonies using agarose gei eiectrophoresis as
described previously. Clones containing inserts in the proper 5‘—3' orientation were identified
by double restriction enzyme digests in some cases, and nucleotide sequence analysis
employing the Sequenase system in other cases. Clones harbouring inserts of interest were
grown on a large scale and the plasmid DNA isolated as described previously. The clones
were grown initially in the presence of ampicillin and were amplified in the presence of 250
H g/ml chloramphenicol.
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Transfection of Yb-| Promoter and Promoter Deletions into Mammalian Cells
Chimeric plasmids were introduced into a human hepatoma cell line (Hep G2) in order
to study transient expression of the Yb^ promoter-CAT chimeric genes. Hep G2 cells were
grown in Eagle's minimum essential medium, nonessential amino acids, sodium pyruvate, 10%
(vol/vol) fetal bovine serum, penicillin at 10 units/ml, and streptomycin at 10 units/ml at 37° C
in a 7% CO2 chamber. All cell culture work was performed in a sterile environment.
For the transfections, 10/xg of CsCI purified plasmid DNA was mixed with 240/i I of
sterile H2O and 31 ^1 of 2 M CaCI2 (123). This mixture was added to 250^1 of 2 x HBS, pH
p c
7.12 and the precipitated DNA was added to a 25 cm flask containing approximately 0.6 x 10
cells (70% confluence) in 4 ml enriched media. The cells were incubated at 37° C in a 5-7%
CO2 environment for 4-5 hr. The media was removed and the cells rinsed with PBS. Cells
were then subjected to a glycerol shock by incubation at room temperature in the presence of
15% glycerol for 2 min. Cells were then rinsed with room temperature media followed by
addition of 4-5 ml fresh media and incubation overnight at 37° C in 5-7% CO2. After overnight
recovery, cells were incubated in the presence of either 50 m M BNF, 50 mM 3MC, or 2 mM PB
overnight, to determine the effect of the xenobiotics on transcriptional activity of the Ybi
promoter and promoter variants.
Cells were harvested in a nonsterile environment. Briefly, the media was removed, the
cells rinsed twice with room temperature PBS. The cells were removed from the side of the
flask by treatment with 1 ml trypsin-EDTA for 2-3 min. The cells were rinsed off of the flask with
4 ml PBS, placed in a conical tube, and spun at 1000 rpm for 4 min. The supernatant was
aspirated and the pellet was resuspended in 100 m I of 0.25 M Tris pH 7.5-7.8. The cells
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were transferred to a 1.5 ml microfuge tube and lysed by three successive incubations in a dry
ice/EtOH bath for 5 min then at 37° C for 5 min (with mixing between the 37° C and dry ice
incubation). The cell lysate was collected by centrifugation at 15,000 rpm for 4 min. The
supernatant was transferred to a new tube and the lysates stored at -20° C (short term) and -
70° C (long term).
Protein Assay
The cell extracts were subjected to protein quantitation using a Biorad Protein Assay,
a colorimetric assay for measuring total protein concentration. The assay is based on the
color change of a coomassie blue G-250 dye in response to various concentrations of protein.
The dye has an absorbance maximum at 595 nM and thus the A5g5 was recorded for all
samples. A linear regression program was utilized to calculate the protein concentration of the
cell extracts.
Chloramphenicol Acetyl Transferase Assay (CAT)
Protein concentrations were normalized for all CAT assays. From 5-50 /x 9 of protein
(depending on cell type) were incubated in 0.25 M Tris-HCI, pH 7.5 (to 160/il), 0.5/iCi ^^C-
chloramphenicol, and 20/il of 4 mM acetyl CoA (124). The mixtures were incubated at 37° C
for 60 min and placed on ice. The reaction mixtures were then extracted with 200^1 ethyl
acetate. The upper aqueous phase was removed to a new 1.5 ml tube and the bottom layer
re-extracted with 200/iI ethyl acetate. The aqueous phases were pooled, dried under vacuum,
resuspended in 25-30I ethyl acetate and spxDtted onto a thin layer chromatography (TLC)
plate. The TLC plate was placed in a tank which had been equilibrated with 100 ml
chloroform;methanol (95:5) for 45 min -1 hr. The plate was allowed to air dry, covered with
Saran Wrap, and subjected to autoradiography.
RESULTS AND DISCUSSION
Isolation of a glutathione S-transferase Ybi gene
One million plaques from a rat liver Haelll genomic library cloned into A Charon 4A
were plated and screened byjoMy hybridization to a '^'"P-cDNA probe. The probe was
prepared by nick translation of the glutathione S-transferase cDNA clone, pGTA/C44. A partial
restriction map of pGTA/C44 is shown in Fig. 7.
Screening of the plaques resulted in the isolation of six clones containing sequences
complementary to glutathione S-transferase Ybi friRNA. Positive plaques were subjected to
3 additional rounds of screening in order to achieve plaque purity. A typical autoradiogram
from each cycle of screening is represented in Fig. 8. Pure plaques were propagated and
phage DNA isolated as described in Methods. The size of the insert(s) in each cione was
determined by restriction digestion of the phage DNA with EcoRI. The digests were
fractionated on a 1% agarose gel. The restriction digest of the clones is shown in Fig. 9.
Southern blot analysis was utilized to positively identify the putative Ybi gene.
Genomic DNA was transferred to a nylon membrane and hybridized to ^^P-labeled fragments
representing the 5', middle, and 3' regions of the Ybi mRNA. The fragments were generated
by restriction digestion of pGTA/C44 with Pst1 /Sphi. One clone, A GTA/C22, harbored inserts
which hybridized to all 3 regions of the Ybi ftiRNA and was selected for further
characterization (Fig. 10).
Subcloning of Ybi genomic fragments
The glass bead purified EcoRI digested genomic fragments, approximately 2.5 Kb and
5 Kb in size, were annealed to EcoRI digested dephosphorylated pBr325 and used to
transform E coLi HB101. Since the inserts were cloned Into the site of chloramphenicol










Fig. 7. Partial restriction map of pGTA/C44
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Fig. 8. Autoradiograph ofiniitu hybridization of plaques. Plaques were Ivsed in situ and
the DNA was denatured and fixed to gene screen. The DNA was hybridized to a
^^P-cDNA probe (pGTA/C44) prepared by nick translation. Hybridizing plaques
were subjected to 3 additional cycles of screening until plaque purity was
achieved. Figure A depicts round 1, B - round 2, C - round 3, D - round 4.
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Fig. 9. EcoRI digestion of positive clones on 1% agarose stained with ethidium bromide.
The ciones were digested to completion with EcoRI and fractionated on a 1%
agarose gel in the presence of 0.5 jJ. g/ml ethidium bromide. Lanes 1 & 8 contain
Hindill digested A DNA o x 174 DNA fragments. Digestion of 5 ciones yielded 4
bands: 19 Kb, 11 Kb, 4.4 Kb, 3 Kb (Lanes 2-6). Digestion of the 6th clone yielded













Fig. 10. Southern blot analysis of AGTA/C22. DNA was digested with EcoRl, fractionated
on 1% agarose in the presence of 0.5Mg/ml ethidium bromide, transferred to
nylon discs and subjected to hybridization to ^^P-DNA fragments obtained by
Psti /Sphi digestion of pGTA/C44. The Pstl/SphI fragments represent the 5',
middle, and 3' regions of the glutathione S-transferase-Yb-) mRNA.
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(Tet*^) and chloramphenicol sensitive (Cam®). Clones harboring inserts of the appropriate size
were grown on a large scale and the plasmid DNA isolated.
Characterization of a giutathione S-transferase Yb-j gene
The rat liver glutathione S-transferase Yb-| structural gene is contained within two
EcoRi fragments. The two genomic clones, pGTA 5 K and pGTA 2.5 K, were subjected to DNA
sequence analysis using a novel approach involving the use of double stranded plasmid DNA
template and synthetic oligonucleotide. Oligonucleotides were synthesized on a Biosearch
Model 8600 DNA synthesizer employing beta-cyanoethyl, solid phase chemistry. Three
different sequencing systems were evaluated and in some cases modified for use in DNA
sequence analysis. The sequencing reactions were carried out as described in Methods.
Briefly, purified ds DNA was denatured in alkali, annealed to the desired oligonucleotide
primer, and the primer extended in the presence of one labeled dNTP and the other three cold
dNTPs.
The exon-intron structure of the Yb-j gene is represented in Fig. 11. The gene spans a
distance of approximately 5.5 Kb and consists of eight exons separated by seven introns. The
nucleotide sequence of each exon and all exon-intron junctions are presented in Fig. 12A and
Fig. 12B.
Exon 1 is 73 bp in length and encodes the 5'-untranslated region of the Yb-| mRNA
from nucleotides 1 -37 as well as amino acids 1 -12 of the Yb-i polypeptide. Exon 2 is 76 bp in
length and encodes amino acids 13-37 of the Ybi subunit. Exons 3 and 4 are 65 bp and 82 bp
in length and encode amino acids 38-59 and 60-86, respectively. Exons 5 and 6 are 101 and
96 bp in length and encode amino acids 87-120 and 121-152, respectively. Exon 7 is 111 bp in
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Fig, 11. The exon-intron structure of glutathione S-transferase-Yb-] gene. The gene spans









M P M I
AAGTCGOACaCACAGGrCAATrCTGCTGAAGCCAAATAGAGAAGACCAaGCGCCAGAACC ATG CCT ATG ATA
LGYWNVRG







ctctctcccag CTG ACA CAC CCG ATC CGC CTG CTC CTG GAA TAC ACA GAC TCA AGC TAT GAG
EKRYAMGD





A P D Y
gttcttgctactggtcgaatgggacagtggggtgatttcttttcacatcctcttgtccaccacagCT CCC GAC TAT
DRSQWLNEKFKLGLDFPN





Fig. 12A. Nucleotide sequence of the glutathione S-transferase-Yb-| gene. EcoRI
fragments containing the GST-Yb-| gene inserted into pBr325, were subjected
to double-stranded nucleotide sequence analysis bas^ on the dideoxy chain
termination methcxJ. Nucleotides in the exons are denoted by uppercase
letters, whereas nucleotides in the introns are denoted by lowercase letters.
The TATA box and the poly(A) signal are underlined. The ATG initiation ccxJon
is enclosed in a box. The transcription initiation site is indicated by +1.
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LPYLIDGSRKITQSNAIMR
agCTG CCC TAG TTA ATT GAT GGA TCG CGCJVAG ATT ACC GAG AGC AAT GCC ATA ATG CGC
YLARKHHL
TAC CIT GCC CGC AAG CAC CAC CTG Tgtgagtggggctggctgcaggggcggggagtggtggagagtctcct
INTRON 4CGETEEERI
tggcttggctgggttgggatctgagggtgctgcgtgtgctacagCT GGA GAG ACA GAG GAG GAG C^ ATT
RADIVENQVMDNRMQLIMLC
CGT GCC GAC ATT GTG GAG AAC CAG GTC ATG GAC AAC CGC ATG CAG CTC ATC ATG CTT TGT
Y N P D F






KPEFLKTI PEK MKL YSEFLG
AAG CCA GAG TTC AAG^CC ATC CCT GAG AAG ATG AAG CTC TAC TCT GAG TTC CTG GGC
KRPWFAGDK
AAG CGA CCA TGG ITT GCA GGG GAC AAG gtaaaggcacagggtgggaggaggagctgccattctcxcctgg
INTRON 6 V T Y V D F L A Y D
tgtcagattcgcagagcgctcacccttggcttcctgcagGTC ACC TAT GTG GAT TTC CTT GCT TAT GAC
ILDQYHIFEPKCLDAFPNLK
ATT err GAC CAG TAC CAC ATT TTr GAG CCC AAG T6C CTG GAC GCC TTC CCA AAC CTG AAG
D F L A R F E INTRON 7
GAC TTC CTG GCC CGC TTC GAG gtgatgcccttgatcctgcttcctcttg ~2Kb
G L K K I S A Y
agacctgagctctggctgtgtccttcccaatttgcagGGC CTG AAG AAG ATC TCT GCC TAC
MKSSRYLSTPIFSKLAQWSN






Fig. 12B. Nucleotide sequence of the glutathione S-transferase Ybi gene continued.
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and encodes amino acids 190-218 of the Yb-| mRNA as weii as 363 bp of the 3' untranslated
region of the Ybi mRNA.
The sizes of introns 1-4 in the giutathione S-transferase Yb^ gene were determined by
nucleotide sequence anaiysis, whiie the sizes of introns 5 and 7 were approximated using
restriction mapping. The sizes of all exons and introns are listed in Table 6. All exon-intron
boundaries comply with the canonical GT/AG rule (125).
The sequence of the Yb-] structural gene is 99% homologous to the Yb^ cDNA clone,
pGTA/C44 differing by 3 nucleotides which results in 2 amino acid substitutions. Comparison
of the amino acid sequence of the Ybi gene to the amino acid sequence of other genes from
the Yb2 gene family which have been characterized, revealed interesting homology to the Yb2
and Yb4 genes characterized by Lai et al. (107). Over the protein coding region, there is
greater than 80% nucleotide sequence identity between the Yb^ and Yb2 genes (Fig. 13).
Interestingly, there is a greater than 40% nucleotide sequence identity between the introns of
these two genes.
Determination of transcription initiation site of Yb^ gene
The site of transcription initiation was determined by primer extension analysis. The
length of the extended primer was 54 bps, (Fig. 14) which corresponds to the guanine marked
+ 1 in Ybi gene sequence (Fig. 12). An (A+T) rich region starts 29 bps upstream from the
start of transcription and represents the TATA box. Also of interest, 70 bp downstream of the
+1 site is the AUG translation initiation codon.
Characterization of the 5' flanking region of the glutathione S-transferase Yb-| gene.
The genomic clone, pGTA 2.5 K, was analyzed further by DNA sequence analysis and
found to contain approximately 1.9 Kb of 5' flanking sequence, containing the putative Yb-j
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Table 6. Sizes of exons and introns in the giutathione S-transferase Yb-) gene










Table 7. Summary of intron sequence homology
between Yb^ and Yb2 genes
DNA Location Length (bo)* % Homology
Intron 1 294 41
Intron 2 351 49
Intron 3 247 89
Intron 4 90 70
5' Region of Intron 5 10 90
3' Region of Intron 5 57 75
Intron 6 82 74
5' Region of Intron 7 28 86
Data for the Yb2 gene was taken from Ref. 107.
‘Length is relative to sequence in Yb-i gene.
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Fig. 13.
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Yb, MaMILGYWNVRGLTHPIRLLLEYTDSNYEEKRYVMGDAPNFDRSQWLSBKFNLGL
Ybi -P S A DY N K
Ybj -P-T DI A-A T TS—D-K-S DY K
Ybj -P-T DI A-A S T D N K
60 70 80 90 100 110
/////»
Yb4 DIPNLPYLIDGSHKVTQSNAILRYLGRKHNLCGETEEERIRVDTLENQVMDTRIH
Ybi -F R-I M A H A-IV N-MQ
Ybj -F 1 V A LQ
Ybj -F 1 1 L--N-MV
120 130 140 150 160
f / / / f
Yb4 LMIVCCSPDFEKQKPEFLKSIPEKMKIYSEFLGKRPWFAGDKVTYVDFLAYDILD
Ybi -IML-YN T L
Ybj -AM—Y RK—Y-EGL L Q N-I y—V—
Ybj -ARL-YN L--GY-EQL-GM-RL I-F 1 V-E
170 180 190 200 210
/ f / / /
Yb4 QYRMFEPECLDAFPNLKDFLARFEGLKKISAYMKSSSFLPRPVFTKIPQWGTD
Ybi —HI K RY-ST-I-S-XA--SNK
Ybj -H-I K V D GR—SK-I-A-MAF-NPK
Ybi RNQV—AT 1 D R L MAI—SK
Comparison of the amino acid sequence of glutathione S-transferase-Yb-|, Yb2,
Yb3, and Yb4 subunits.
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Fig. 14. Primer extension analysis. The start of transcription of the Yb^ structural gene was
determined by primer extension analysis. An oligonucleotide primer, 5'-CCC-AGT-
ATC-ATA-GGC-ATG-GTT-CTG-GCG-CTG-GCG-CTG-TGG 3', which represents a 33
bp fragment complementary to the 5' region of Ybi mRNA was synthesized and
hybridized to 30/ig of poly(A‘'') RNA isolated from livers of rats treated with 3-
methylcholanthrene. The primer was extended using reverse transcriptase and
electrophoresed on a 12% polyacrylamide/8 M urea sequencing gel. Lane 1
contains the primer extended product. The arrow indicates the longest extended
primer. Lanes 2-5 contain Ml3 mp19 which was used as size markers.
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promoter region. The clone is represented in Fig. 15.
Plasmid DNA from pGTA 2.5 K was subjected to restriction digestion with EcoRI and
Bglll, thus generating a 2 Kb genomic fragment containing approximately 1.9 Kb of 5' flanking
sequence and 175 bp of sequence downstream of the TATA box. The 175 bp encompass all
of exon 1 and 75 bp of intron 1 (Fig. 15). The 2 Kb fragment was made blunt ended and
isolated using glass bead elution as described in Methods.
Generation of Ybi -SVgCAT chimeric gene and transfection into mammalian cells.
The purified 2 Kb genomic fragment was inserted upstream of the structural gene
encoding chloramphenicol acetyl transferase (CAT) in the pSVgCAT reporter vector. The
vector was digested with Hindlll and made blunt ended prior to insertion of the Ybi gene
fragment. The chimeric gene was transformed into SCSI cells and tranformants were plated
onto LB plates containing ampicillin. Putative positives were identified by either in situ
hybridization or double restriction enzyme digestion with BamHI /Sad. Two clones, one
harboring the insert in the desired 5'—3' orientation and the other in the reverse 3'—5’
orientation, were identified and subsequently introduced into Hep G2 cells (a human hepatoma
derived cell line) via CaP04 mediated transfection. Results of CAT assays perfomed on cell
lysates are represented in Fig. 16. No detectable CAT activity was evident for either of the
Ybi constructs, while the pS\/2CAT construct, which is under the control of the S\/40
promoter and enhancer, showed appreciable activity under identical conditions. CAT activity
refers to the conversion of ^'^C-chloramphenicol j^'^C-CAM] to its acetylated products -1
acetyl CAM, 3 acetyl CAM and 1,3 diacetyl CAM.
Identical results, that is, no appreciable CAT activity, were obtained when the Ybi ’CAT



























Fig. 15. Partial restriction map of pGTA 2.5K. The plasmid, pGTA 2.5K, contains
approximately 1.9 kb of 5' flanking sequence and 500 bp of sequence











Fig. 16. Autoradiograph of CAT assay using lysed human Hep G2 cells transfected with
glutathione S-transferase CAT chimeric plasmids. Transient assays were performed
in human Hep G2 cells by using PSV2CAT, pGTA 1.9 CAT, and pGTA 1.9 RCAT. All
CAT assays were done in duplicate. The substrate of the reaction [^'^C]
chloramphenicol migrates closest to the origin on the TLC plate, whereas the
acetylated products have a faster mobility in the soivent system.
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Fig. 17. Autoradiograph of CAT assay using lysed rat H5-6 cells transfected with glutathione
S-transferase - chimeric plasmids. Transient assays in the presence and absence of
50 /i M BNF were performed in rat H5-6 cells by using PSV2CAT, pGTB 1.6 CAT,
pGTA 1.9 CAT, and pGTA 1.9 RCAT. All assays were done in duplicate. The
migration of substrate and products is described in Figure 16.
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containing the glutathione S-transferase Yb-j -CAT gene were treated with -naphthofiavone, a
compound known to induce the glutathione S-transferase-Ya CAT gene in celi culture, no
activity was detected (Fig. 17).
Construction of Yb-| -CAT chimeric genes using Bal-31 exonuciease and the poiymerase chain
reaction.
Carefui examination of the nucieotide sequence of the Yb-j 2 Kb structurai gene
fragment, which was previousiy inserted into pSVqCAT, reveaied that the fragment contained
ali of exon 1 which contained two initiation codons (AUG). The iack of CAT activity of the initiai
construct couid be explained if translation were initiated at the start site of the Yb^ gene
thereby resulting in a frameshift and synthesis of a non-functional protein.
Two different techniques were utilized to generate Yb-j-CAT chimeric genes which did
not contain the AUG initiation codon. The first technique is a novel procedure employing jn
vitro amplification of DNA, using Taq polymerase to amplify the Yb^ structural gene fragment.
The previously constructed Yb^-CAT chimeric gene was used as the template and
oligonucleotide complementary to the 5' and desired 3' end were designed and used in the
amplification to generate pGTA 1.7 CAT. A schematic depiction of this clone is represented in
Fig. 18.
The second technique involved exonuclease digestion of the initial construct Yb-| CAT
with Bal-31 after restriction digestion of the plasmid DNA with Sadi. A unique Sacil site is
located 75 bp downstream of the transcription initiation site (Fig. 15). After digestion of the
plasmid with Sadi and subjection to Bal-31 digestion, the linearized fragment was made blunt
ended using Klenow and re-ligated in presence of T4 ligase. The chimeric genes were












pGTA 1.7 CAT B
EXON
Fig. 18. Schematic diagram of pGTAl .9CAT, pGTA1.7CAT and pGTA1.7CATB. The
chimeric piasmids were constructed as described in the Discussion. THe
piasmids pGTA1.9CAT, pGTAl .7CAT, and pGTA1.7CATB were constructed by
EcoRi/Bgiil digestion of pGTA2.5K, by PCR, and by Bal 31 treatment,
respectively.
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plates containing ampicillin. A schematic depiction of this clone, pGTA 1.7 CATS, is also
included in Fig. 18.
Positive clones, containing the Ybi gene fragment in the proper orientation, as
determined by double restriction digestion with BamHI and Sad, were grown on a large scale.
Plasmid DNA was transfected into Hep G2 cells as described previously. The results of CAT
assays of the cell lysates are presented in Fig. 19 and 20. This data demonstrated that the Ybi
structural gene fragment contained a functional promoter and that comparable CAT activity
resulted from generation of the PCR clone and from Bal-31 exonuclease treatment. The
question of transcriptional activity of the Yb-| promoter was answered and another issue
addressed - that is the induction of the Yb-j gene activity in response to xenobiotic
administration. Cells which had been transfected with the active Yb^ -CAT constructs were
treated with SMC and activity of the cell lysates was determined. The results, depicted in Fig.
19 and 20 demonstrated that the Yb-| gene activity is not induced in Hep G2 cells in response
to SMC administration. The activity of the Yb-j -CAT chimeric gene was not elevated in
response to Pb treatment of either Hep G2 or H5-6 cells (data not shown). These data
suggested that regulatory element(s) that confer SMC inducibility are lacking from the first
1700 bp of the Ybi gene. The studies of Pb induction of the Yb-j gene activity await the
availability of a Pb responsive cell line.
Localization of the element required for basal expression of Yb^ gene.
A series of deletions of the pGTA 1.7 CAT gene fragment were constructed using PCR
and inserted into pSVgCAT. The deletions contained 1200,1000, 760, 610, 550, 510, 480, 280,
120, and 50 bps of 5' flanking sequence (Fig. 21). The smallest mutant, pGTA OCAT contains






















































Fig. 19. Autoradiograph of CAT assay using iysed human Hep G2 celis transfected with
glutathione S-transferase-CAT chimeric plasmids. Transient assays in the presence
and absence of 3MC were performed in human Hep G2 cells by using pGTA 1.7
CAT, pGTB .892 CAT, and pGTA 1.7 CAT B. All assays were done in duplicate. The
migration of substrate and products is described in Figure 16.
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Fig. 20. Autoradiograph of CAT assay using lysed human Hep G2 cells transfected with
glutathione S-transferase-CAT chimeric plasmids. Transient assays in the presence
and absence of SMC were performed in human Hep G2 cells by using pGTB .892
CAT, pGTA 1.7 CAT, and pGTA .76 CAT. All assays were done in duplicate. The








































Fig. 21. Schematic diagram of PCR generated Ybi-CAT chimeric plasmids.
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identical to the 3' end of the initial PCR construct. The 5' and 3' ends are highlighted in Fig. 22.
These mutants were transfected into Hep G2 cells and the activity of the cell lysates was
quantitated using CAT assays. The results of the CAT assays are presented in Fig. 23-27.
All transfections were performed a minimum of 3 times with at least two different
preparations of DNA. These data suggested that while marginal differences exist in the activity
of the first 10 deletions, there is a distinct decrease (60-70%) in transcriptional activity when the
sequence up to 50 bp upstream of the TATA box is removed. This suggested that this region
contains the element(s) responsible for basal expression of the Ybi gene (Fig. 26-27).
Contained within this region are the TATA element, the transcription start site, and 50 bp
upstream of the TATA element.
74
[aGQACAGCAC CGGCTGTGACi TCCTAGCTTC aggtctctcc ATGTCCCCAA TCCCCACTGC TCCCTGTTGC
CTTTTAGAGA CCTCTCTCAT TAAAAGGGGT GATGCTCTTG GAGTCTGGGG ACCCTGCGTT GAGCACTTGC
CTGTCCTAGC CCTTATCCCT GTCTGCAGAG CGACTCTGTC CTCTGAAGGG TTCCAGGGCT CTGGCCTCCC
TTCCAGGCCC CTCTGAGCCC TTTGTTCTGG AGAGTATGGA TTCCTTGTCT TTCCTTCCAC TCCCCTTCTC
TAGTTCCCAT A6TGCATGAA AATGTGCTGA TGCGCCTCAT TCATACTTCA AATTATCTCC TGTAGTTCCA
GAAAACTGCT GCTAAAGCCC AGTGACATGG CTGTTCGATC GATCTCCAAG GACCTCGAGA CGGTGTGGCT
TCTCTAAGTC TAGGATGAGA TGGCCTCTCG TTGTCCTGCA CCCACACTGC ACACCTCTCT GTGTGTGAGG
1.2
TGACACACTG GCTTCATACC CATAGTCTTA ATAAAAGATG ACTTATCCAA AATGTACTCT IctgcagagcaI
|GCXSCItT*SC.iCtTTTGACCT GTAAACTGTT TTTAGTCTCC TCGTCCGTCA TTTGTTTTTC ATCTGATAAG
TTTCTGTAAA CAAGGTGATG TCATCCTCAG
1.0
GCCAATTAAC CACAAGCCTC TTGGTTATGG AAGAGTCTCT
TGCCCTTCAA GGAAGAAAGT aggoIggcag GACAGTGTTC ttggiIagggg ATTGTCCTTG TGAAGGTTAT
ACCACAGGAC ATATATCCCA GGATAACCTG AATTTGAGCC ACCCTGTCAT ATACAAACAC ATGTCAGGAG
CCTGGGGCCA GGTCCAGCAT CTAGGGATGT GGACAGCTGC AGGTCTAGCT TTGGGCTCCT TGTGTCCTGT
0.7«
tJggctcccttIGCAGAGTGTT ACAGGCTCCC ATGTGTACAG CATCCTGTTG TCCTTTGAAA ACGAGCCTCT
Igcactciact "gJsgttctgtc AGCGTGACGT GTCGCCAGCT GTGGCTTCCC TCAGACTGCC agtccctctc
TGTGTCTGAG TTAGTTCATA AACATGGCCA AGACTGATTA GGTTTATAAC TGATAACAGA GGACTGAdrr]
0.55
ICCCAAATCTC AAGGAATATt GAGACTTGTT TGTCTCTGCC
0.51
CCGAGGCTGT TTCCATGTCG CCA;iCTGTTCl





























Fig. 22. Nucleotide sequence of 5' flanking region of the GST-Ybi gene. The boxes
represent the sequence of oligonucleotides used to generate the Yb-i-CAT chimeric
constructs by the polymerase chain reaction. The TATA box is underlined in bold
print. The 3' end of all PCR generated clones is double underscored. The asterisk
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Fig. 23. Autoradiograph of CAT assay using lysed human Hep G2 cells transfected with
glutathione S-transferase-CAT chimeric plasmids. Transient assays were performed
in human Hep G2 cells by using no plasmid, pSVqCAT, PSV2CAT, pGTA 1.7 CAT,
pGTA 1.2 CAT, pGTA 1.0 CAT, pGTA .76 CAT, pGTA .51 CAT, pGTA .48 CAT, and
pGTA .28 CAT. The migration of substrate and products is described in Figure 16.
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Fig. 24. Autoradiograph of CAT assay using iysed human Hep G2 ceils transfected with
glutathione S-transferase-CAT chimeric plasmids. Transient assays were performed
in human Hep G2 cells by using PSV2CAT, pGTA 1.7 CAT, pGTA 1.0 CAT, pGTA .76
CAT, pGTA .55 CAT, pGTA .51 CAT, pGTA .48 CAT, pGTA .28 CAT, and pGTA .12
CAT. Assays were done in triplicate. The migration of substrate and products Is
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Autoradiograph of CAT assay using iysed human Hep G2 ceiis transfected with
giutathione S-transferase-CAT chimeric piasmids. Transient assays were performed
in human Hep G2 ceiis by using PSV2CAT, pGTA 1.7 CAT, pGTA 1.0 CAT, pGTA .76
CAT, pGTA .61 CAT, pGTA .55 CAT, pGTA .51 CAT, pGTA .48 CAT, pGTA .28 CAT,
pGTA .12 CAT and pGTB 1.6 CAT. Ali assays were performed in tripiicate. The
migration of substrate and products is described in Figure 16.
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Fig. 26. Autoradiograph of CAT assay using lysed human Hep G2 cells transfected with
glutathione S-transferase chimeric plasmids. Transient assays were performed in
human Hep G2 cells by using pSYgCAT, PSV2CAT, pGTA 1.7 CAT, pGTA 1.2 CAT,
pGTA .28 CAT, and pGTA 0 CAT. All assays were done in triplicate. The migration

























Flg. 27. Autoradiograph of CAT assays using iysed human Hep G2 ceils transfected with
glutathione S-transferase-CAT chimeric plasmids. Transient assays were performed
in human Hep G2 cells by using pGTA 1.7 CAT, pGTA .28 CAT, pGTA .12 CAT,
pGTA 50 CAT, and pGTA 0 CAT. Assays were done in triplicate. The migration of
substrate and products is described in Figure 16.
CONCLUSION
Many pathological conditions, such as cancer, are caused by exposure to toxic
agents. It is therefore important to understand the toxic effects and metabolism of compounds
to which living beings are exposed. In the body, foreign compounds usually undergo chemical
transformations, such as oxidations, reductions, hydrolyses, and syntheses (conjugations).
Most often, transformations of foreign compounds result in less active products. The
tranformations are generally catalyzed by enzymes, many of which occur in the liver. One
group of such enzymes is the glutathione S-transferases. The transferases are caiied
detoxicating enzymes since by cataiyzing the conjugation with glutathione and rendering
nonpolar foreign molecules more hydrophilic, they initiate the first stage of the mercapturic
acid pathway for elimination of foreign compounds from the body (68).
It has been well documented that the transferases, as well as other drug metabolizing
enzymes such as NADH cytochrome P-450 reductase and epoxide hydroiase, are regulated at
the transcriptional level, in response to xenobiotic administration. Recent work on the
transferases has focused on the regulation of the rat and mouse Ya genes and on the Yp gene.
The evolution and regulation of the Yb genes constitute the focus on the work
described in this text. A full-length Yb-] gene was isolated from a rat liver genomic library using
the Ybi cDNA clone, pGTA/C44, as a probe. Nucleotide sequence anaiysis reveaied that the
gene spans a distance of approximateiy 5.5 Kb and is comprised of eight exons separated by
seven introns. The nucleotide sequence of the Ybi structurai gene is 99% homoiogous to the
Ybi cDNA cione, pGTA/C44. The characterization of the Yb-j gene provides the final evidence
that the gene is a member of a distinct gene family.
A comparison of the nucleotide sequence of the Ybi 3*^^ Yb2 (92) genes revealed
significant homology in the 5' end of the coding region as weli as in the middie; the 3‘ ends are
-80-
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divergent. Interestingly, there is also significant homology throughout the introns of these two
genes. This data suggests that gene conversion, a nonreciprocal recombination event, may
have played a role in the evolution of the two genes.
Isolation and characterization of the gene has facilitated an analysis of the 5' flanking
region of the gene. A DNA fragment containing approximately 1.7 Kb of upstream sequence
(and various deletions of the sequence) was inserted into pSVgCAT, a reporter vector which
lacks a promoter and contains the structural gene which encodes chloramphenicol acetyl
transferase. The chimeric genes were introduced into mammalian cells, which lack
endogenous CAT activity, and CAT activity was monitored using thin layer chromatography.
The data suggests that the regulatory elements responsible for basal expression of the Ybi
gene are contained within an 80 bp region of sequence upstream of the transcription start site.
This region contains a TATA element, transcription start site, and 50 bp of sequence upstream
of the TATA element. A deletion mutant lacking this region consistently yielded CAT activities
which were approximately 30% of the activity obtained using chimeric genes containing this
region.
Several labs have demonstrated that the glutathione S-transferase Ya and Yb mRNAs
are elevated in the liver of rats administered SMC. No elevation in Yb^ promoter activity was
detected when rat or human hepatoma cells which had been transfected with the Yb-)
promoter-CAT chimeric genes, were treated with this xenobiotic. When cells which had been
transfected with the glutathione S transferase Ya promoter were treated with SMC, Ya
promoter activity was elevated 4-5 fold. This data suggests that the the regulatory element
which confers SMC inducibility is absent from the first 1700 bp of the Yb-i gene. The task of
identifying the regulatory element(s) responsible for activation of the Yb-| gene activity in
-82-
response to phenobarbital adminstration was hindered by the lack of availability of a
phenobarital-responsive cell line. The use of primary hepatocyte cultures may be necessary to
examine phenobarbital induction.
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